Opus Genetics is trading at $3.49 (+6.7%) in after-hours trading as the stock continues to rebound from recent downside pressure.
- The upward move follows several weak sessions tied to broader biotech and risk-asset volatility rather than any new company-specific catalyst.
- No fresh FDA updates, earnings reports, or major corporate news have been identified today to drive the price action.